Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|May 22, 2020
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective AgentsSilvia Franchini, Pasquale Linciano, Giulia Puja, et al.
European Journal of Medicinal Chemistry|April 14, 2023
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cellsAndrea Galbiati, Stefania Bova, Raffaella Pacchiana, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 11, 2026
Targeting ALDH7A1 with covalent inhibitors reveals new chemical space for prostate cancer therapyRaffaella Gallo, Antonio Scarano, Eleonora Gianquinto, et al.
Chemical Science|January 26, 2024
Correction: A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Chemical Science|January 5, 2024
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Chemmedchem|May 23, 2024
Boosting the Impact of EFMC Young Scientists Network Through the Creation of Working GroupsMichele Mari, Caroline Lanthier, Matic Proj, et al.
Journal of Medicinal Chemistry|September 3, 2016
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate SynthaseRosaria Luciani, Puneet Saxena, Sachin Surade, et al.
Chemmedchem|November 21, 2024
Highlights from the Lowlands: Early Career Researchers Shine at Medicinal Chemistry Frontiers 2024Sean M McKenna, Chiara Borsari, Sean Chin Chan, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine MoietyChiara Borsari, Denise Rageot, Florent Beaufils, et al.
Pageof 5